was not associated with the evening in middle-aged women.
No significant association was found between PCOS and the evening chronotype based on both the Morningness-Eveningness Questionnaire and self-assessment.
The most common chronotype among both women with and without PCOS was the intermediate chronotype.
Hyperandrogenic PCOS phenotypes did not show a difference in chronotype compared to non-hyperandrogenic phenotypes.
Both PCOS and non-PCOS groups with an evening chronotype reported higher levels of depressive and anxiety symptoms.
Evening chronotype was linked to increased use of sleep medication in both groups.
Simplified
INTRODUCTION: Circadian rhythm disruption has been associated with the risk of (PCOS), as the evening (EC) shares several traits with PCOS, including metabolic disorders, cardiovascular diseases, and psychiatric disorders. It has been suggested that the biological clock could be targeted with new, preventive, and therapeutic strategies for PCOS in women with biorhythm disorders. We evaluated inner circadian rhythmicity in middle-aged women with PCOS in a population-based setting, focusing on whether women with PCOS and an EC have a specific subtype in relation to their clinical characteristics.
MATERIAL AND METHODS: The data derived from the Northern Finland Birth Cohort, a population-based longitudinal birth cohort of 12 058 individuals born in 1966. We compared the circadian phenotype between 314 women with PCOS (according to the Rotterdam criteria) and 1248 women without PCOS at age 46 years using the validated Finnish shortened 6-item Morningness-Eveningness Questionnaire (sMEQ) and the single-item self-assessed morningness-eveningness question.
RESULTS: PCOS was not associated with the EC by the sMEQ (p = 0.495) or self-assessment (p = 0.303). The self-assessed morningness-eveningness values differed from the sMEQ chronotype distribution (p < 0.001), nevertheless, the most frequent chronotype was the intermediate chronotype (IC) determined by both chronotyping methods (sMEQ PCOS 47.7% vs. 45.2% non-PCOS; self-assessment PCOS 66.5% vs. 68.4% non-PCOS). The hyperandrogenic PCOS phenotypes A-C did not differ from the non-hyperandrogenic phenotype D as for the chronotype (p = 0.271). The EC was associated in both groups with depressive and anxiety symptoms (PCOS p = 0.012, non-PCOS p < 0.001) and the use of sleep medication (PCOS p = 0.017, non-PCOS p < 0.001).
CONCLUSIONS: The EC was not over-represented in middle-aged women with PCOS or in the hyperandrogenic PCOS phenotypes A-C in our study. This does not support the need for chronotyping in the comprehensive assessment of women with PCOS. However, as chronotypes tend to change with aging, cross-sectional studies in different age groups are warranted to draw conclusions on the role of chronotypes in PCOS and the associated metabolic risks.
Key numbers
13.9%
Evening Prevalence
Percentage of women with classified as evening .
66.5%
Intermediate Prevalence
Percentage of women with self-assessing as intermediate .
p = 0.012
Depressive Symptoms Association
Statistical significance of depressive symptoms associated with evening in women with .
Full Text
We can’t show the full text here under this license.